Dr. Tugal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
19 Bradhurst Ave
Hawthorne, NY 10532Fax+1 914-594-2143- Is this information wrong?
Education & Training
- Hacettepe University FOMClass of 1974
- Icahn School of Medicine at Mount Sinai/Kravis Children'sFellowship, Pediatric Hematology/Oncology
Certifications & Licensure
- NY State Medical License 1986 - 2025
- ME State Medical License Active through 2009
- CT State Medical License 1998 - 1998
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism Start of enrollment: 2017 Jun 02
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- A pilot safety, feasibility and efficacy study of an oral anticoagulant, apixaban, in secondary prophylaxis of a primary venous thromboembolism in children and adolesc...Ashley Pinchinat, Oya Levendoglu-Tugal, Yara Perez, Emily Thatcher, Neida Otero, Arvind Budhram, Harshini Mahanti, Erin Morris, Liana Klejmont, Edo Schaefer, Adele Bru...> ;British Journal of Haematology. 2023 Jun 1
- 1 citationsHemolysis in Early Infancy: Still a Cause of Cholestatic Neonatal Giant Cell Hepatitis.Hao Wu, Oya Tugal, Antonio R. Perez-Atayde> ;The American Journal of Surgical Pathology. 2021 Dec 1
- Primary Lung Cribriform Adenocarcinoma With Squamoid Morules Harboring Somatic CTNNB1 Mutation in a Never-Smoked Healthy Adolescent.Hao Wu, Qiqi Ye, Dana Razzano, Oya Tugal, Jeremy Rosenblum, Tracey L. Weigel, Minghao Zhong> ;Pediatric and Developmental Pathology. 2020 Sep 13
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: